Fluent Hydra Sativa Dominant Vape Cartridge – 600mg
Creative and Focused Sativa
Hydra is a Sativa-dominant strain produced from a hybrid Cannabis sativa and Cannabis indica plant and has a ratio of 30:1 THC:CBD. Hydra has a unique earthy smell and taste with hints of pine. The Sativa’s effects are generally happy, bubbly, and euphoric, spurring energy and creativity. These qualities make Hydra generally ideal for daytime oriented activities. Hydra is a whole plant product that contains THC, CBD and the full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that are believed to contribute the medicinal properties of Cannabis.
Current medical literature supports the use of THC rich products for the treatment of all conditions approved for medical cannabis.
Strain: Jack Herer
CBD Content: Approximately 1%
THC Content: Approximately 60%
THC to CBD Ratio: 30:1
Dosing Units: 600 mg cartridge contains 2 mg THC/inhalation
Total Doses: Approx: 300 inhalations per cartridge (1ml)
Sold By: Fluent
Leave Your Review: Write A Review
Request Online Ordering For Fluent Products
Out of stock
“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.
Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms. If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.
Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.
Hydra® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Hydra®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.